Nephrogen Inc.
New York, NY
- UEI
- MHJ4VX93MPJ3
- CAGE
- 7X6Z0
- Primary NAICS
- Not on record
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Physical address
- 1361 Amsterdam Ave # 320, New York, NY 10027, USA
- Website
- nephrogenbiotech.com
- Founded
- 2015
- Employees
- 1-10
- Estimated annual revenue
- $0-$1M
- Industry
-
- Health Care
- Health Care Equipment & Services
- Health Care Providers & Services
- Health Care Services
- SIC code
- 80 Health Services
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Grant awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Crispr-CAS editing as a genetic cure for autosomal dominant polycystic kidney disease | National Institute of Diabetes and Digestive and Kidney Diseases (NIH) | $650,000 |
Quick answers
Is Nephrogen Inc. registered in SAM.gov?
Yes. Nephrogen Inc.'s SAM.gov registration is active through February 9, 2027.
What is Nephrogen Inc.'s most recent federal award?
Nephrogen Inc.'s most recent federal grant award is Crispr-CAS editing as a genetic cure for autosomal dominant polycystic kidney disease (R41DK138689), from National Institute of Diabetes and Digestive and Kidney Diseases (NIH), on September 19, 2023.
On GovTribe
See Nephrogen Inc.'s full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors